マルチモダル療法による二次予防 LDL受容体ゼロのLDL-C標的 ホモジゴス家族性高コレステロール症
Areej Alkhairy1, Pinhao Xiang2, John K Khoo3
1Division of Endocrinology and Metabolism, University of British Columbia, Vancouver, Canada; Division of Endocrinology and Metabolism, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.
JACC. Case reports
|August 22, 2025
まとめ
ホモジゴス家族性高コレステロール血症 (HoFH) は,多様式療法による積極的な治療を必要とします. 併用治療は,小児の低密度脂質タンパク質コレステロール (LDL- C) を著しく低下させ,心血管疾患の進行を防ぐことができます.
科学分野:
- 遺伝学
- 心臓病科
- 薬理学について
背景:
- ホモジゴス家族性高コレステロール血症 (HoFH) は,希少で重度の遺伝疾患である.
- これは主にLDLR遺伝子の病原性変異によって引き起こされます.
- 治療を受けないHoFHは,しばしば20歳未満の早期死亡につながる.
研究 の 目的:
- 小児患者の重度の HoFH の症例を報告する
- HoFHの総合的なマルチモデルの治療戦略の有効性を評価する.
- 心血管疾患の進行に対する治療の影響を評価する.
主な方法:
- HoFHと非常に高いLDL- Cのレベルを持つ4歳の男の子が治療されました.
- 遺伝子解析により,最小残留活性 (LDLR-null) を有する二代性LDLR変種が確認されました.
- 治療には最大用量のロスウスタチン,エゼチミブ,血交換,ロミタピド,エヴィナキュマブが含まれていた.
主要な成果:
- 併用療法により,ガイドラインで推奨されるLDL- C値 (< 70 mg/ dL) が達成されました.
- 治療中に早発性冠動脈疾患の進行は観察されなかった.
- このマルチモダルのアプローチにより,以前は達成できなかったLDL-Cの減少が可能になりました.
結論:
- HoFHの効果的な管理には,多様式な脂質低下療法が必要です.
- 現在の治療法では,LDL-Cを大幅に減らし,血管の合併症を予防できます.
- 積極的なLDL- C低下は,HoFH患者における肝臓移植の必要性を回避する可能性があります.
関連する概念動画
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
869
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
869
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:23Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
38
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
38